Natural Health Trends Corp 8-K, filed May 14, 2024
Natural Health Trends Corp (NHTC)
8-K
2024-05-14
For: 2024-05-14
View Original
Added on
April 09, 2026
About this 8-K
Natural Health Trends Corp filed this 8-K on May 14, 2024.
Items reported
- Item 5.07: Shareholder vote results
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
|
|
||
|
Date of Report (Date of earliest event reported)
|
||
(Exact name of registrant as specified in its charter)
|
|
|
|
|
(State or other jurisdiction of incorporation)
|
(Commission File Number)
|
(IRS Employer Identification No.)
|
(Address of principal executive offices, including zip code)
+852 -3107-0800
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
|
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Securities registered pursuant to Section 12(b) of the Exchange Act:
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
|
|
|
The
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
|
|
Emerging growth company
|
☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Item 5.07 Submission of Matters to a Vote of Security Holders.
On May 14, 2024, the Company held its 2024 annual meeting of stockholders in Rowland Heights, California. At the annual meeting, there were 11,516,773 shares entitled to vote, and 8,841,238 shares (76.8%) were represented at the meeting in person or by proxy.
At the annual meeting, Yiu T. Chan, Randall A. Mason, Chris T. Sharng and Ching C. Wong were elected directors by a plurality of the votes.
Also at the annual meeting, the Company’s stockholders approved, by advisory vote, the compensation of the Company's named executive officers; ratified the appointment of Marcum LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024; and approved and adopted the amendment to the Company's certificate of incorporation to provide for the exculpation of certain of our officers, as permitted by recent amendments to the Delaware General Corporation Law.
The following summarizes the vote results for these matters submitted to the Company’s stockholders for action at the annual meeting:
|
1.
|
The election of the following persons to serve as directors of the Company until the next annual meeting of stockholders:
|
|
Nominees
|
For
|
Withheld
|
Broker Non-Votes
|
|||
|
Yiu T. Chan
|
6,297,368
|
153,851
|
2,390,019
|
|||
|
Randall A. Mason
|
6,297,418
|
153,801
|
2,390,019
|
|||
|
Chris T. Sharng
|
6,414,982
|
36,237
|
2,390,019
|
|||
|
Ching C. Wong
|
5,276,571
|
1,174,648
|
2,390,019
|
|
2.
|
The proposal to approve, by advisory vote, the compensation of the Company's named executive officers:
|
|
Votes For
|
Votes Against
|
Abstentions
|
Broker Non-Votes | |||
|
6,259,999
|
166,046
|
25,174
|
2,390,019 |
|
3.
|
The proposal to ratify the appointment of Marcum LLP as the Company’s independent registered public accounting firm for fiscal year ending December 31, 2024:
|
|
Votes For
|
Votes Against
|
Abstentions
|
||
|
8,755,344
|
63,174
|
22,720
|
|
4.
|
The proposal to approve and adopt the amendment to the Company’s certificate of incorporation to provide for the exculpation of certain of our officers, as permitted by recent amendments to the Delaware General Corporation Law:
|
|
Votes For
|
Votes Against
|
Abstentions
|
Broker Non-Votes | |||
|
6,352,022
|
62,243
|
36,954
|
2,390,019 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: May 14, 2024
|
NATURAL HEALTH TRENDS CORP.
|
|||
|
By:
|
/s/ Timothy S. Davidson
|
||
|
Timothy S. Davidson
|
|||
|
Senior Vice President and Chief Financial Officer
|
|||